Skip to content
Menu

Enanta Pharmaceuticals, Inc. ENTA

Full chart Compare
Set alert

Price alert · ENTA

All alert types
8.69 USD -1.98 (-18.56%)

Regular-session close

8.99 +0.30 +3.45%

Pre-market · Nov 18, 4:15 AM ET

8.61 Day range 10.80
8.61 52-week range 17.15
YTD
-44.90%
1 year
-32.22%

Revenue & Expenses

Revenue Profit Costs
Other Income$110.35MNet Loss$68.25MExpenses$178.60MGross Loss$53.18MSelling, General & Admin$36.84MResearch & Development$88.55MIncome Tax$40.00KRevenue$63.00M

Latest period ending Sep 30, 2025 · select a line to chart its full history

ENTA annual income statement
Fiscal yearFY 2025 Sep 30, 2025FY 2024 Sep 30, 2024FY 2023 Sep 30, 2023FY 2022 Sep 30, 2022FY 2021 Sep 30, 2021
65.32M67.64M79.20M86.16M97.07M
65.32M67.64M79.20M86.16M97.07M
-85.35M-121.69M-137.21M-123.84M-109.57M
-81.89M-116.05M-133.82M-121.75M-79.00M
-3.84-5.48-6.38-5.91-3.92
ENTA annual balance sheet
Fiscal yearFY 2025 Sep 30, 2025FY 2024 Sep 30, 2024FY 2023 Sep 30, 2023FY 2022 Sep 30, 2022FY 2021 Sep 30, 2021
32.30M37.84M85.39M47.96M57.81M
280.73M376.65M462.27M375.41M438.79M
216.01M247.84M245.54M54.08M39.36M
57.90M55.47M26.51M25.26M5.33M
64.72M128.81M216.74M321.33M399.43M
ENTA annual cash flow
Fiscal yearFY 2025 Sep 30, 2025FY 2024 Sep 30, 2024FY 2023 Sep 30, 2023FY 2022 Sep 30, 2022FY 2021 Sep 30, 2021
-19.27M-78.76M-103.15M-84.78M-70.00M
40.35M58.23M-53.58M54.90M36.99M
-26.62M-27.63M198.13M20.03M3.08M
-12.90M-17.95M-9.06M-2.13M-750.00K
-5.54M-48.16M41.39M-9.85M-29.93M